iShares Biotechnology ETF $IBB Stake Boosted by TD Private Client Wealth LLC

TD Private Client Wealth LLC grew its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 164.7% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 17,225 shares of the financial services provider’s stock after acquiring an additional 10,717 shares during the period. TD Private Client Wealth LLC’s holdings in iShares Biotechnology ETF were worth $2,907,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Darwin Wealth Management LLC bought a new stake in iShares Biotechnology ETF in the second quarter worth $25,000. Cornerstone Planning Group LLC bought a new stake in iShares Biotechnology ETF in the fourth quarter worth $35,000. Strategic Wealth Advisors LLC bought a new stake in iShares Biotechnology ETF in the fourth quarter worth $35,000. Parkside Financial Bank & Trust boosted its holdings in iShares Biotechnology ETF by 48.6% in the third quarter. Parkside Financial Bank & Trust now owns 266 shares of the financial services provider’s stock worth $38,000 after purchasing an additional 87 shares in the last quarter. Finally, Close Asset Management Ltd boosted its holdings in iShares Biotechnology ETF by 25.5% in the third quarter. Close Asset Management Ltd now owns 345 shares of the financial services provider’s stock worth $50,000 after purchasing an additional 70 shares in the last quarter. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Trading Down 1.7%

Shares of NASDAQ:IBB opened at $164.03 on Tuesday. iShares Biotechnology ETF has a 1 year low of $119.78 and a 1 year high of $179.64. The firm has a fifty day moving average price of $169.14 and a 200 day moving average price of $169.70.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Tuesday, March 17th were issued a $0.1218 dividend. The ex-dividend date was Tuesday, March 17th. This represents a $0.49 dividend on an annualized basis and a yield of 0.3%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.